Enyedy Mark J 4
4 · ImmunoGen, Inc. · Filed Feb 5, 2024
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Enyedy Mark J
DirectorChief Executive Officer
Transactions
- Award
Restricted Stock Unit
2024-02-01+140,357→ 140,357 totalExercise: $0.00→ Common Stock (140,357 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]The RSUs vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.